Dennis J. Slamon, MD, PhD, on New Approaches to Breast Cancer Treatment

Posted: Wednesday, April 21, 2021

Dennis J. Slamon, MD, PhD, of the UCLA David Geffen School of Medicine, talks about the future directions in breast cancer research that he is most enthusiastic about, including new ways to deliver targeted therapies via antibody-drug conjugates, bispecific antibodies, cell-directed therapies, or proteolysis-targeting chimeras. He also muses on the role that serendipity plays in advancing the field.